Lyerly HK - Search Results

1

Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.

Barrott JJ, Hughes PF, Osada T, Yang XY, Hartman ZC, Loiselle DR, Spector NL, Neckers L, Rajaram N, Hu F, Ramanujam N, Vaidyanathan G, Zalutsky MR, Lyerly HK, Haystead TA. Barrott JJ, et al. Among authors: lyerly hk. Chem Biol. 2013 Sep 19;20(9):1187-97. doi: 10.1016/j.chembiol.2013.08.004. Epub 2013 Sep 12. Chem Biol. 2013. PMID: 24035283 Free PMC article.

2

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

Hobeika AC, Morse MA, Osada T, Ghanayem M, Niedzwiecki D, Barrier R, Lyerly HK, Clay TM. Hobeika AC, et al. Among authors: lyerly hk. J Immunother. 2005 Jan-Feb;28(1):63-72. doi: 10.1097/00002371-200501000-00008. J Immunother. 2005. PMID: 15614046

3

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.

Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. J Transl Med. 2005 Feb 21;3(1):9. doi: 10.1186/1479-5876-3-9. J Transl Med. 2005. PMID: 15723705 Free PMC article.

4

Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.

Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. Clin Cancer Res. 2005 Apr 15;11(8):3017-24. doi: 10.1158/1078-0432.CCR-04-2172. Clin Cancer Res. 2005. PMID: 15837756 Clinical Trial.

5

Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.

Osada T, Morse MA, Lyerly HK, Clay TM. Osada T, et al. Among authors: lyerly hk. Int Immunol. 2005 Sep;17(9):1143-55. doi: 10.1093/intimm/dxh292. Epub 2005 Jul 18. Int Immunol. 2005. PMID: 16027139

6

NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity.

Osada T, Clay T, Hobeika A, Lyerly HK, Morse MA. Osada T, et al. Among authors: lyerly hk. Cancer Immunol Immunother. 2006 Sep;55(9):1122-31. doi: 10.1007/s00262-005-0089-3. Epub 2005 Nov 5. Cancer Immunol Immunother. 2006. PMID: 16273350 Free PMC article. Clinical Trial.

7

Role of natural killer cell function in dendritic cell-based vaccines.

Woo CY, Clay TM, Lyerly HK, Morse MA, Osada T. Woo CY, et al. Among authors: lyerly hk. Expert Rev Vaccines. 2006 Feb;5(1):55-65. doi: 10.1586/14760584.5.1.55. Expert Rev Vaccines. 2006. PMID: 16451108 Review.

8

Recent clinical progress in virus-based therapies for cancer.

Woo CY, Osada T, Clay TM, Lyerly HK, Morse MA. Woo CY, et al. Among authors: lyerly hk. Expert Opin Biol Ther. 2006 Nov;6(11):1123-34. doi: 10.1517/14712598.6.11.1123. Expert Opin Biol Ther. 2006. PMID: 17049011 Review.

9

Dendritic cell-based immunotherapy.

Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK. Osada T, et al. Among authors: lyerly hk. Int Rev Immunol. 2006 Sep-Dec;25(5-6):377-413. doi: 10.1080/08830180600992456. Int Rev Immunol. 2006. PMID: 17169781 Review.

10

Immunotherapeutic targeting of Wilms' tumor protein.

Hutchings Y, Osada T, Woo CY, Clay TM, Lyerly HK, Morse MA. Hutchings Y, et al. Among authors: lyerly hk. Curr Opin Mol Ther. 2007 Feb;9(1):62-9. Curr Opin Mol Ther. 2007. PMID: 17330403 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page